GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Lanxess AG (XTER:LXS) » Definitions » Research & Development

Lanxess AG (XTER:LXS) Research & Development : €100 Mil (TTM As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Lanxess AG Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Lanxess AG's Research & Development for the three months ended in Mar. 2024 was €28 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €100 Mil.

Lanxess AG Research & Development Historical Data

The historical data trend for Lanxess AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lanxess AG Research & Development Chart

Lanxess AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 114.00 108.00 95.00 102.00 99.00

Lanxess AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.00 25.00 24.00 23.00 28.00

Lanxess AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €100 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lanxess AG  (XTER:LXS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lanxess AG Research & Development Related Terms

Thank you for viewing the detailed overview of Lanxess AG's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Lanxess AG (XTER:LXS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Lanxess AG (XTER:LXS) » Definitions » Research & Development
Comparable Companies
XTER:VBK XTER:NTG XTER:MZX XTER:BNN FRA:3330 XTER:WCH XTER:EVK XTER:1COV XTER:BNR LIN XPAR:AI SHW ECL APD XSWX:SIKA XSWX:GIVN SHSE:600309 ISX:TPIA LYB BOM:500820
Traded in Other Exchanges
LNXSY:USA LNXSF:USA 1LXS:Italy LXSd:UK 0H7I:UK LX9B:Germany LXS:Germany LXS:Germany LXS:Germany LXS:Austria
Address
Kennedyplatz 1, Cologne, DEU, 50569
Website
https://www.lanxess.com
Lanxess is a German chemical company that was originally spun out of Bayer. Lanxess has visibly decommoditised its portfolio in recent years by divesting its synthetic rubber business and is moving toward becoming a specialty chemicals company in the fields of consumer protection chemicals, specialty additives, intermediates, and engineering plastics.
Executives
Frederique Van Baarle Board of Directors
Oliver Stratmann Board of Directors
Matthias Zachert Board of Directors
Dr. Anno Borkowsky Board of Directors
Dr. Hubert Fink Board of Directors
Michael Pontzen Board of Directors

Lanxess AG (XTER:LXS) Headlines

No Headlines